Why the Market is Wrong about Johnson & Johnson

The bluest of blue chip stocks, health care conglomerate Johnson & Johnson (NYSE: JNJ), reported strong second quarter results and yet shares tumbled almost 2%.

Operationally J&J couldn't have been stronger; growing its topline 9% to 19.5 billion, and excluding one-time items, embarrassing Wall St earnings estimates at $1.66 per share, 11 cents better than expected. The pharma division continues its streak of monster growth, clocking in 21% gains, while its Medical Devices and Consumer segments chipped in strong international performances.

However, despite its recent success, J&J's full year guidance may be the culprit for its troubles on the market today.

In this special edition of Market Checkup, health care analysts David Williamson and Michael Douglass focus exclusively on J&J's second quarter results. Watch and find out everything worth knowing about the stock and how investors should react to its earnings.

Leaked: This coming blockbuster will make every biotech jealous
The best biotech investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not just how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool's new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.

  


Read/Post Comments (0) | Recommend This Article (4)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 3030455, ~/Articles/ArticleHandler.aspx, 11/27/2014 2:50:05 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement